<DOC>
	<DOCNO>NCT01307189</DOCNO>
	<brief_summary>This study design test follow hypothesis : A ) The acute long-term ( 3 week ) bronchodilator-induced change exercise tolerance physiological response endurance shuttle walk great tiotropium compare placebo COPD patient . B ) Three week bronchodilation associate increase activity daily live evaluate use London Chest Activity Daily Living scale .</brief_summary>
	<brief_title>Effects Tiotropium Walking Capacity Patients With COPD</brief_title>
	<detailed_description>Objectives : The purpose study compare acute bronchodilator-induced change exercise tolerance endurance shuttle walk tiotropium placebo COPD patient . Also , evaluate physiological response ( VE , VO2 , VCO2 , heart rate ) endurance shuttle walk patient COPD patient . Finally , compare long-term ( 3 week ) bronchodilator-induced change exercise tolerance endurance shuttle walk tiotropium placebo COPD patient evaluate impact long-term ( 3 week ) bronchodilation activity daily live evaluate use London Chest Activity Daily Living scale . Methods : This double-blind , randomize parallel-group study . Due long action duration tiotropium ( 4 week ) , cross-over design , use ipratropium versus placebo study , appropriate present study . The study require five visit Centre de recherche de l'Hopital Laval . The first visit include review consent form , pulmonary function testing , maximal incremental shuttle walk . The following two visit ( Visit 2 3 ) use familiarize participant shuttle endurance walk test . Salbutamol ipratropium bromide stop 6 hour prior visit remain medication allow study period ( see ) continue prescribe . The goal familiarization reduce learn effect typically occur individual completes endurance test several time 3 . On visit 4 , patient randomize receive one two treatment : placebo tiotropium 18 ug ( Spiriva ) use handihaler device . Pulmonary function test perform London Chest Activity Daily Living scale administer . Two hour follow inhalation first study dose , pulmonary function test repeat patient perform endurance shuttle walk . They provide enough medication study duration discharge . The procedure Visit 4 complete three week later , visit 5 . Data analysis : The main outcome endurance time day 21 . This variable compare two treatment arm use unpaired t-test . The endurance time day 0 also compare two treatment arm use procedure . The time course cardiorespiratory parameter dyspnea time compare two exercise modality . Comparisons do use repeated measure design ( ANOVA ) . Significance level set p value 0.05 . The two familiarization endurance shuttle walk test perform day -10 day -5 use evaluate test-retest variability procedure .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>age &gt; 50 year , smoke history &gt; 10 packs/year , FEV1 &lt; 70 % predict FEV1/FVC &lt; 70 % . respiratory exacerbation within 2 month precede study , history asthma , significant O2 desaturation ( SaO2 &lt; 85 % ) rest exercise , presence another pathology could influence exercise tolerance .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease ( COPD )</keyword>
	<keyword>Exercise</keyword>
	<keyword>Endurance shuttle walk test</keyword>
	<keyword>Bronchodilation</keyword>
	<keyword>Tiotropium</keyword>
</DOC>